Skip to content

DarioHealth Corp.: 10-Q filed 2013-05-14

What DarioHealth Corp. reported in its quarterly report filed 2013-05-14 (fiscal Q1 2013): 21 published measures, 61 facts as tagged in accession 0001144204-13-028673.

This filing

Form
10-Q (quarterly report)
Filed
2013-05-14
Fiscal period
fiscal Q1 2013
Accession
0001144204-13-028673 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DarioHealth Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-03-312,063,663USD
At 2012-12-312,315,453USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-03-31-4,085,618USD
At 2012-12-31-1,069,043USD
At 2011-12-31193,144USD
At 2011-08-100USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-03-31294,897USD
At 2012-12-311,230,034USD
At 2012-03-311,499,067USD
At 2011-12-31908,765USD
At 2011-08-100USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-5,226,869USD90
2011-08-11 to 2013-03-31-11,298,791USD599
2012-01-01 to 2012-12-31-5,686,573USD366
2012-01-01 to 2012-03-31-570,883USD91
2011-08-11 to 2011-12-31-385,349USD143

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-971,291USD90
2011-08-11 to 2013-03-31-4,005,479USD599
2012-01-01 to 2012-03-31-316,010USD91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-03-31461,872USD90
2011-08-11 to 2013-03-311,104,057USD599
2012-01-01 to 2012-03-319,533USD91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-03-31498,026USD90
2011-08-11 to 2013-03-315,468,383USD599
2012-01-01 to 2012-03-31915,845USD91

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-461,872USD90
2011-08-11 to 2013-03-31-1,168,007USD599
2012-01-01 to 2012-03-31-9,533USD91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-03-311,291,959USD
At 2012-12-31617,364USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-03-311,712,268USD90
2011-08-11 to 2013-03-312,713,910USD599
2012-01-01 to 2012-03-31126,593USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-3,076,167USD90
2011-08-11 to 2013-03-31-7,285,288USD599
2012-01-01 to 2012-03-31-494,746USD91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-03-31739,424USD
At 2012-12-311,666,544USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-03-311,195,543USD
At 2012-12-31566,755USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-03-31675,414USD90
2011-08-11 to 2013-03-312,254,574USD599
2012-01-01 to 2012-03-31171,670USD91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-03-3115,146,033shares
At 2012-12-3114,547,689shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-03-317,211,659USD
At 2012-12-315,001,425USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-03-31408,578USD
At 2012-12-31401,522USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-311,903,725USD90
2011-08-11 to 2013-03-314,237,699USD599
2012-01-01 to 2012-03-31323,076USD91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-03-31117,267USD90
2011-08-11 to 2013-03-31142,088USD599
2012-01-01 to 2012-03-311,503USD91

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-14,705USD90
2011-08-11 to 2013-03-31-286,995USD599
2012-01-01 to 2012-03-31-97,254USD91

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-2,150,702USD90
2011-08-11 to 2013-03-31-4,013,503USD599
2012-01-01 to 2012-03-31-76,137USD91

Inspect the source

Entity
DarioHealth Corp. / CIK 0001533998
Captured
2026-09-20T09:16:34.053Z
SEC response SHA-256
8c524c61fa46c2531eea7286cfb0614b41c397fc0b2f416d3e5df141148eb6b9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001533998.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))